Inhibikase Market Cap from 2010 to 2024
| IKT Stock | USD 1.84 0.03 1.66% |
Market Cap | First Reported 2010-12-31 | Previous Quarter 7.8 M | Current Value 7.4 M | Quarterly Volatility 32.3 M |
Check Inhibikase TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibikase main balance sheet or income statement drivers, such as Interest Expense of 89.9 K, Net Interest Income of 935.8 K or Selling General Administrative of 5.3 M, as well as many exotic indicators such as Price To Sales Ratio of 24.7, Dividend Yield of 0.0 or PTB Ratio of 0.65. Inhibikase financial statements analysis is a perfect complement when working with Inhibikase TherapeuticsInc Valuation or Volatility modules.
Inhibikase | Market Cap |
Latest Inhibikase TherapeuticsInc's Market Cap Growth Pattern
Below is the plot of the Market Cap of Inhibikase TherapeuticsInc over the last few years. It is Inhibikase TherapeuticsInc's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibikase TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Market Cap | 10 Years Trend |
|
Market Cap |
| Timeline |
Inhibikase Market Cap Regression Statistics
| Arithmetic Mean | 62,286,568 | |
| Geometric Mean | 46,165,842 | |
| Coefficient Of Variation | 51.82 | |
| Mean Deviation | 26,722,293 | |
| Median | 79,338,026 | |
| Standard Deviation | 32,275,376 | |
| Sample Variance | 1041.7T | |
| Range | 95.4M | |
| R-Value | (0.74) | |
| Mean Square Error | 511.7T | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | (5,322,341) | |
| Total Sum of Squares | 14583.8T |
Inhibikase Market Cap History
About Inhibikase TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Inhibikase TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Inhibikase TherapeuticsInc investors use historical funamental indicators, such as Inhibikase TherapeuticsInc's Market Cap, to determine how well the company is positioned to perform in the future. Although Inhibikase TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Inhibikase TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inhibikase TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inhibikase TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inhibikase TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Market Cap | 7.8 M | 7.4 M |
Pair Trading with Inhibikase TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inhibikase TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Inhibikase Stock
| 0.67 | EQ | Equillium | PairCorr |
The ability to find closely correlated positions to Inhibikase TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inhibikase TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inhibikase TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inhibikase TherapeuticsInc to buy it.
The correlation of Inhibikase TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inhibikase TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inhibikase TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inhibikase TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Inhibikase TherapeuticsInc Correlation against competitors. For more information on how to buy Inhibikase Stock please use our How to Invest in Inhibikase TherapeuticsInc guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Inhibikase Stock analysis
When running Inhibikase TherapeuticsInc's price analysis, check to measure Inhibikase TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase TherapeuticsInc is operating at the current time. Most of Inhibikase TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Inhibikase TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase TherapeuticsInc's price. Additionally, you may evaluate how the addition of Inhibikase TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Inhibikase TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibikase TherapeuticsInc. If investors know Inhibikase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibikase TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.23) | Revenue Per Share 0.034 | Quarterly Revenue Growth (1.00) | Return On Assets (0.64) | Return On Equity (1.20) |
The market value of Inhibikase TherapeuticsInc is measured differently than its book value, which is the value of Inhibikase that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibikase TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Inhibikase TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibikase TherapeuticsInc's market value can be influenced by many factors that don't directly affect Inhibikase TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibikase TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inhibikase TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibikase TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.